Skip to main content

AbCellera Biologics Inc 10-K for FY2024

AbCellera Biologics Inc. (ABCL)

10-K 2025-02-27 For: 2024-12-31
View Original
Added on April 08, 2026

About this 10-K

AbCellera Biologics Inc filed this 10-K on February 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$28.83M
down 24.2% from $38.03M a year earlier
Net loss
$162.86M
compared with a net loss of $146.4M a year earlier
Diluted EPS
-$0.55
compared with -$0.51 a year earlier